EAACI Congress 2024, Valencia (Spain), 31 May – 03 June 2024

29. May 2024 | News

Saturday, June 1st 12:00 am | Together with Bencard Germany ClinCompetence Cologne presents an interim analysis of a 5 years AIT cohort study in Children, adolescents and adults TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline...

A high-dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio

29. January 2024 | News

Oliver Pfaar1, Angelika Sager2, Ralph Mösges34, Margitta Worm5 Affiliations Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany. ↩︎ LETI Pharma...

Together with the Imperial College London and Inmunotek, Madrid ClinCompetence Cologne present the results of a first-in-human study

19. October 2023 | News

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe and well tolerated – data from 3 sequential trials

16. March 2023 | News

Affiliations Silke Allekotte, PhD Esther Raskopf, PhD Laura England Christian Neuhof Hacer Sahin, PhD Lea Radtke, PhD Christoph Zeyen Lea Decker Elena Xenofontos Friederike Hüffmeier Mandy Cuevas, MD Miguel Casanovas, MD, PhD José. L. Subiza, MD, PhD Enrique...

Mannan-conjugated birch pollen allergoids reduce the combined symptom and medication score in birch pollen allergic patients already in the first treatment year and further decreases with prolonged treatment duration

16. March 2023 | News

Affiliations Laura England Esther Raskopf, PhD Hacer Sahin, PhD Lea Radtke, PhD Christoph Zeyen Lea Decker Elena Xenofontos Friederike Hüffmeier Mandy Cuevas, MD Miguel Casanovas, MD, PhD Enrique Fernandez-Caldas, PhD José. L. Subiza, MD, PhD Silke Allekotte, PhD...